Met Life Investment Management, LLC Annexon, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 64,967 shares of ANNX stock, worth $94,851. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,967
Previous 55,212
17.67%
Holding current value
$94,851
Previous $326,000
2.15%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ANNX
# of Institutions
155Shares Held
98MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$10.8 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$10.2 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$9.62 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$9.2 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$8.22 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $69.5M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...